Milestone Scientific to Exhibit at the Chicago Dental Society's 143rd Midwint...(uncertainties and are based on assumptio...),Health

Date:2/15/2008

uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report on Form 10-KSB for the year ended December 31, 2006. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

FOR MORE INFORMATION, PLEASE CONTACT:

Elite Financial Communications Group, LLC

Dodi Handy, President and CEO, or Daniel Conway, Chief Strategy Officer

407-585-1080 or via email at mlss@efcg.net

'/>"/>

SOURCE Milestone Scientific Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing
2. Vendormate Storms into 2008 with Major Milestones for Hospital Vendor Compliance
3. Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory
4. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
5. Transition Therapeutics Announces Milestone Payment from Elan
6. Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors
7. IBM reports milestone in silicon nanophotonics
8. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
9. Bavarian Nordic Receives $25 Million Milestone Payment From HHS for Fulfilling Contract Milestones
10. Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
11. Marlo Thomas and St. Jude Childrens Research Hospital(R) Announce Hitting The 50-Partner Milestone as They Kick Off the Fourth Annual Thanks and Giving(R) Campaign Which Asks America to Support St. Jude While Shopping This Holiday Season